Antimicrobial Spectrum and Clinical Applications of Linezolid

Clinical Efficacy and Safety

• Linezolid has demonstrated better clinical and microbiological success rates than vancomycin in various infection types, particularly skin and soft tissue infections (Odds Ratio 4.0; 95% CI, 1.3-12.0) 1
• The American College of Clinical Microbiology and Infection recommends linezolid as an effective treatment for complicated skin and soft tissue infections, nosocomial pneumonia, and community-acquired pneumonia 2
• Linezolid has excellent tissue penetration properties, including into the prostate, making it valuable for treating infections in tissues with limited blood supply 3
• The use of linezolid is associated with a risk of thrombocytopenia with prolonged use, according to the Clinical Microbiology and Infection guidelines 2
• The Praxis Medical Insights guideline notes that the suspension formulation of linezolid can be poorly tolerated in children due to its taste 4